Miki, M.; Fujimori, N.; Ueda, K.; Lee, L.; Murakami, M.; Takamatsu, Y.; Shimokawa, Y.; Niina, Y.; Oono, T.; Hisano, T.;
et al. Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study. J. Clin. Med. 2022, 11, 5084.
https://doi.org/10.3390/jcm11175084
AMA Style
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, Shimokawa Y, Niina Y, Oono T, Hisano T,
et al. Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study. Journal of Clinical Medicine. 2022; 11(17):5084.
https://doi.org/10.3390/jcm11175084
Chicago/Turabian Style
Miki, Masami, Nao Fujimori, Keijiro Ueda, Lingaku Lee, Masatoshi Murakami, Yu Takamatsu, Yuzo Shimokawa, Yusuke Niina, Takamasa Oono, Terumasa Hisano,
and et al. 2022. "Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study" Journal of Clinical Medicine 11, no. 17: 5084.
https://doi.org/10.3390/jcm11175084
APA Style
Miki, M., Fujimori, N., Ueda, K., Lee, L., Murakami, M., Takamatsu, Y., Shimokawa, Y., Niina, Y., Oono, T., Hisano, T., Furukawa, M., & Ogawa, Y.
(2022). Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study. Journal of Clinical Medicine, 11(17), 5084.
https://doi.org/10.3390/jcm11175084
